eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-AKRO-Akero Therapeutics Inc

Akero Therapeutics Inc AKRO

‎$‎53.770.05(0.09%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Akero Therapeutics Inc
Today
Create an eToro account to buy AKRO stock on a secure, user-friendly, multi-asset trading platform.
Buy Akero Therapeutics Inc
Buy Akero Therapeutics Inc
Akero Therapeutics Inc AKRO
Buy AKRO
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Hold
Price Target
57.33
Based on analysts who covered AKRO

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Akero Therapeutics Inc News

More about Akero Therapeutics Inc
Akero Therapeutics Inc, based in the US, is a clinical-stage biotechnology firm committed to the advancement of transformative medicines for patients with non-alcoholic steatohepatitis (NASH) and other severe liver diseases.

Akero Therapeutics Inc is mainly recognised for its flagship product, Efruxifermin (EFX), which is designed for NASH treatment. Being an independent entity, Akero stands out in its commitment to medical innovation, especially in the field of NASH, a serious concern with largely unmet needs.

Stay up to date on the share price of AKRO by adding it to your eToro watchlist.
VIEW MORE   

AKRO Stock Price Chart

‎13.63‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset stable trend

The Akero Therapeutics Inc share price is stable this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Akero Therapeutics Inc price today is ‎$‎53.77, a ‎0.09‎% change in the last 24 hours and ‎-0.15‎% in the past week. Akero Therapeutics Inc price changed by ‎81.53‎% in the past year.
AKRO Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
-
Day’s Range
i
Shows the high and low prices of the day.
‎$‎53.59 - ‎$‎53.8
52W Range
i
Shows the high and low prices of the last year.
‎$‎17.81 - ‎$‎58.18
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
-
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-
Revenue
i
The total income generated by this company’s goods and services last year.
-
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
-
Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎53.77
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
-
What Is Akero Therapeutics Inc?
Akero Therapeutics Inc, based in the US, is a clinical-stage biotechnology firm committed to the advancement of transformative medicines for patients with non-alcoholic steatohepatitis (NASH) and other severe liver diseases.

Akero Therapeutics Inc is mainly recognised for its flagship product, Efruxifermin (EFX), which is designed for NASH treatment. Being an independent entity, Akero stands out in its commitment to medical innovation, especially in the field of NASH, a serious concern with largely unmet needs.

Stay up to date on the share price of AKRO by adding it to your eToro watchlist.
Get Started

How can I buy Akero Therapeutics Inc stocks?

To purchase Akero Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Akero Therapeutics Inc (AKRO) page and place an order to buy Akero Therapeutics Inc.
Buy AKRO
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Akero Therapeutics Inc
Invest in Akero Therapeutics Inc
Today
Create an eToro account to buy AKRO stock on a secure, user-friendly, multi-asset trading platform.
Get Started

FAQ

The current price of AKRO is ‎$‎53.77.
The average price target for Akero Therapeutics Inc is ‎$‎57.33. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Akero Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Akero Therapeutics Inc is -
Based on 7 analysts offering recommendations for AKRO in the last 3 months, the overall consensus is Hold.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top